Dr. Utpal P. Dave, MD

Dr. Dave practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Dave's NPI, 1124102231, was assigned on October 25, 2006. Dr. Dave holds Indiana license 01077437A.

Dr. Dave's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Dave's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Dave is also affiliated with IU Health Ball Memorial Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Dave to 1 more hospital, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dave practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dave's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Dave's licenses on file in 2 states: Indiana and Tennessee.

CMS data shows 234 Medicare services from Dr. Dave across 3 procedure codes in 2024, for 65 Medicare patients. Medicare paid $22,097 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Dave in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dave's median patient age at 62, with 42% women.

In 2024, Dr. Dave wrote 160 Medicare Part D claims for 25 patients. 84% of them were for generic drugs. CMS names the drug for 69 of them, across 3 drugs with 11 or more claims each, at $742 in total drug cost. In 2023, CMS named 95 claims across 4 drugs.

Dr. Dave accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dave as offering telehealth.

Dmand AI links 8 papers to Dr. Dave, published from 2010 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Databases, Genetic, Genomics and Skin Neoplasms. Dr. Dave has published most often in Blood. Dr. Dave's most frequent co-authors are Alexander Bick, MD, Michael Crossman Honigberg, MD and Ramesh Kumar, MD.

Dmand AI links Dr. Dave to 2 clinical trials. 1 is still active or recruiting. Conditions studied include COVID-19, Lymphoma, T-Cell, Peripheral and Lymphoma, T-Cell.

CMS Open Payments shows 21 general payments to Dr. Dave from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Acrotech Biopharma LLC paid the most, $4,294.